Medpace Holdings, Inc. (MEDP)
NASDAQ: MEDP · Real-Time Price · USD
608.43
+9.22 (1.54%)
Jan 13, 2026, 4:00 PM EST - Market closed
Medpace Holdings Market Cap
Medpace Holdings has a market cap or net worth of $17.14 billion as of January 14, 2026. Its market cap has increased by 60.90% in one year.
Market Cap
17.14B
Enterprise Value
17.00B
1-Year Change
60.90%
Ranking
Category
Stock Price
$608.43
Market Cap Chart
Since August 11, 2016, Medpace Holdings's market cap has increased from $1.10B to $17.14B, an increase of 1,455.63%. That is a compound annual growth rate of 33.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 12, 2026 | 16.88B | 6.69% |
| Dec 31, 2025 | 15.82B | 53.21% |
| Dec 31, 2024 | 10.33B | 9.79% |
| Dec 29, 2023 | 9.41B | 42.38% |
| Dec 30, 2022 | 6.61B | -15.55% |
| Dec 31, 2021 | 7.82B | 57.08% |
| Dec 31, 2020 | 4.98B | 64.41% |
| Dec 31, 2019 | 3.03B | 60.71% |
| Dec 31, 2018 | 1.88B | 38.21% |
| Dec 29, 2017 | 1.36B | -7.16% |
| Dec 30, 2016 | 1.47B | 33.32% |
| Aug 11, 2016 | 1.10B | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.29B |
| Johnson & Johnson | 492.44B |
| AbbVie | 388.97B |
| UnitedHealth Group | 311.59B |
| AstraZeneca | 295.57B |
| Merck & Co. | 274.34B |
| Novartis AG | 272.98B |
| Novo Nordisk | 263.81B |